Synposis:

Biology offers boundless possibilities, and biotechnology empowers us to harness its potential for transformative impact. Already contributing 6% of global GDP, biotechnology is poised to redefine industries, with bio-based manufacturing projected to supply 60% of human needs by mid-century. Those who strategically navigate this domain will lead the next era of innovation and economic development.

Come explore the critical role of emerging biotechnologies in shaping a secure, competitive, and sustainable future. Discover how public and private sector collaboration can accelerate translational ecosystems that drive technological advancements, policy frameworks, and global leadership in biotechnology. By taking strategic action today, we can ensure that biology becomes a cornerstone of economic resilience and global progress.

Speaker’s bio:

Drew Endy is a science fellow and senior fellow (courtesy) at the Hoover Institution. He leads Hoover’s Bio-Strategy and Leadership effort, which focuses on keeping increasingly biotic futures secure, flourishing, and democratic. Professor Endy also researches and teaches bioengineering at Stanford University, where he is the Martin Family University Fellow in Undergraduate Education, senior fellow (courtesy) of the Freeman Spogli Institute for International Studies, and faculty co-director of degree programs for the Hasso Plattner Institute of Design. Professor Endy helped launch new undergraduate majors in bioengineering at both MIT and Stanford and the International Genetically Engineered Machine (iGEM) competition, which involves thousands of students annually. Endy has served on the US National Science Advisory Board for Biosecurity; the National Academies of Sciences, Engineering, and Medicine Committee on Science, Technology, and Law; the International Union for Conservation of Nature’s Synthetic Biology Task Force; and, briefly, the Pentagon’s Defense Innovation Board. He currently serves on the World Health Organization’s Advisory Committee on Variola Virus Research; the Organization for Economic Co-operation and Development’s (OECD) Global Forum on Technology’s synthetic biology task force; and the Defense Science Board’s Emerging Biotechnology and National Security Task Force. Endy earned his PhD from Dartmouth in biotechnology and biochemical engineering and has been recognized in Esquire magazine as one of the seventy-five most influential people of the twenty-first century.